Michael R. McKellar, BA
Advertisement
Articles by Michael R. McKellar, BA
This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.
Advertisement
Latest Updated Articles
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: April 23rd 2014 | Updated:
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: March 18th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
3
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
4
Body Size, Metabolism Impact Psoriasis Severity and Biologic Response
5
